Skip to main content icon/video/no-internet

The evaluation and treatment of substance-related problems vary by life phase. As such, understanding the special needs of elders with regard to substance use issues has increased significantly in recent times. In 1900, people 65 years of age and older constituted 4% of the U.S. population, whereas today they are approximately 13%. By the year 2010, baby boomers (e.g., the exceptionally large birth cohort born from 1946 and 1964) will start to turn 65, magnifying this aging trend. By 2045, the number of elderly persons will likely exceed the number of children (15 or younger) for the first time in history. Despite this marked shift in demographics, research on elder substance use treatment has not increased at the same rate. This causes concern because of the increasing number of elderly individuals likely to require substance-related treatment services and a number of factors putting these individuals at higher risk for developing substance-related disorders.

Risk Factors Unique to the Elderly

Individuals over the age of 65 disproportionately consume approximately 30% of all prescribed drugs and are the largest consumers of nonprescribed over-the-counter medications. They are three times as likely to use prescription drugs as younger individuals and spend more than $15 billion on these medications each year. This expenditure is fourfold greater per capita than that of younger generations. Furthermore, 22% of elders who receive Medicare use at least one prescription medication with addiction potential. For example, prescriptions are commonly written for opioid analgesics and for central nervous system depressants (e.g., benzodiazepines such as Valium or Ativan). In fact, approximately 40% of benzodiazepine prescriptions go to the elderly. And because these medications may rapidly produce psychological and physical dependence, they have great potential for problems. Such problems may then be complicated because the drugs may interact with the large number of other medications taken by elderly individuals. Over the course of one month, 60% to 70% of individuals 65 years of age or older take one or more medication combinations that put them at risk for experiencing an adverse drug reaction.

Another factor contributing to increasing risk is medication noncompliance or misuse. Substance misuse broadly refers to erratic use, underuse, or overuse, with the most common form being missed doses. Forgetting to take medication or intentionally skipping doses are sometimes to blame, complicated further when individuals try to compensate by doubling the amount at the next dosing. In fact, approximately 10% of elderly individuals report taking extra doses, and only about half of elderly individuals take their medications as prescribed. Even worse, medication compliance decreases as the number of prescribed medications increases.

Increased risk also develops from age-related changes in physiology (e.g., body composition and vital organ function changes). These can alter the metabolism, excretion, and distribution of drugs. For instance, drugs may become more potent and their effects less predictable with such physiological changes. For example, relative to youth, elders have higher blood alcohol levels after consuming similar amounts of alcohol.

Elder baby boomers may further be at increased risk for substance-related disorders because of social characteristics of their birth cohort. Increased exposure to recreational substance use and more tolerant attitudes toward use, compared to prior generations, are anticipated risks. The prevalence of illicit drug use among these individuals has consistently remained higher than age-matched samples from previous generations.

...

  • Loading...
locked icon

Sign in to access this content

Get a 30 day FREE TRIAL

  • Watch videos from a variety of sources bringing classroom topics to life
  • Read modern, diverse business cases
  • Explore hundreds of books and reference titles

Sage Recommends

We found other relevant content for you on other Sage platforms.

Loading